These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31680044)

  • 1. Infection prevention and control in patients with cystic fibrosis (CF): Results from a survey in 35 German CF treatment centers.
    Meyer S; Nüßlein T; Nährlich L; Bend J; Gärtner B; Becker SL; Simon A
    J Cyst Fibros; 2020 May; 19(3):384-387. PubMed ID: 31680044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review.
    Festini F; Buzzetti R; Bassi C; Braggion C; Salvatore D; Taccetti G; Mastella G
    J Hosp Infect; 2006 Sep; 64(1):1-6. PubMed ID: 16835001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current infection control practices used in Australian and New Zealand cystic fibrosis centers.
    Stockwell RE; Wood ME; Ballard E; Moore V; Wainwright CE; Bell SC
    BMC Pulm Med; 2020 Jan; 20(1):16. PubMed ID: 31952502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different opinions of physicians on the importance of measures to prevent acquisition of Pseudomonas aeruginosa from the environment.
    Steinkamp G; Ullrich G
    J Cyst Fibros; 2003 Dec; 2(4):199-205. PubMed ID: 15463874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995).
    Frederiksen B; Koch C; Høiby N
    Pediatr Pulmonol; 1999 Sep; 28(3):159-66. PubMed ID: 10495331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients.
    Robinson P; Carzino R; Armstrong D; Olinsky A
    J Clin Microbiol; 2003 Dec; 41(12):5741. PubMed ID: 14662972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
    Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
    J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients.
    van Mansfeld R; de Vrankrijker A; Brimicombe R; Heijerman H; Teding van Berkhout F; Spitoni C; Grave S; van der Ent C; Wolfs T; Willems R; Bonten M
    PLoS One; 2016; 11(6):e0157189. PubMed ID: 27280467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre - results of a 10-year prospective study.
    Wiehlmann L; Cramer N; Ulrich J; Hedtfeld S; Weissbrodt H; Tümmler B
    Int J Med Microbiol; 2012 Mar; 302(2):69-77. PubMed ID: 22196973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved patient safety through reduced airway infection rates in a paediatric cystic fibrosis programme after a quality improvement effort to enhance infection prevention and control measures.
    Savant AP; O'Malley C; Bichl S; McColley SA
    BMJ Qual Saf; 2014 Apr; 23 Suppl 1():i73-i80. PubMed ID: 24608553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection prevention and control in cystic fibrosis: One size fits all The argument against.
    Smyth AR; Smith SJ; Rowbotham NJ
    Paediatr Respir Rev; 2020 Nov; 36():94-96. PubMed ID: 31629644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
    Tümmler B; Koopmann U; Grothues D; Weissbrodt H; Steinkamp G; von der Hardt H
    J Clin Microbiol; 1991 Jun; 29(6):1265-7. PubMed ID: 1907611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative hygienic surveillance of contamination with pseudomonads in a cystic fibrosis ward over a 4-year period.
    Bosshammer J; Fiedler B; Gudowius P; von der Hardt H; Römling U; Tümmler B
    J Hosp Infect; 1995 Dec; 31(4):261-74. PubMed ID: 8926376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segregation and use of nonshared care settings reduce the risk of multiresistant P. aeruginosa infection. Re: Davies et al., "Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation," Pediatr Pulmonol 2003;35:253-256.
    Festini F; Ballarin S; Loganes C
    Pediatr Pulmonol; 2003 Aug; 36(2):171; author reply 172. PubMed ID: 12833499
    [No Abstract]   [Full Text] [Related]  

  • 18. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis.
    Geddes DM
    Lancet; 2001 Aug; 358(9281):522-3. PubMed ID: 11520516
    [No Abstract]   [Full Text] [Related]  

  • 19. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper aero-digestive contamination by Pseudomonas aeruginosa and implications in Cystic Fibrosis.
    Rivas Caldas R; Boisramé S
    J Cyst Fibros; 2015 Jan; 14(1):6-15. PubMed ID: 24933711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.